A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects

DSpace/Manakin Repository

A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects

Citable link to this page

 

 
Title: A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects
Author: Shen, Yan; Huang, Jinsha; Liu, Ling; Xu, Xiaoyun; Han, Chao; Zhang, Guoxin; Jiang, Haiyang; Li, Jie; Lin, Zhicheng; Xiong, Nian; Wang, Tao

Note: Order does not necessarily reflect citation order of authors.

Citation: Shen, Y., J. Huang, L. Liu, X. Xu, C. Han, G. Zhang, H. Jiang, et al. 2016. “A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects.” Frontiers in Aging Neuroscience 8 (1): 117. doi:10.3389/fnagi.2016.00117. http://dx.doi.org/10.3389/fnagi.2016.00117.
Full Text & Related Files:
Abstract: Parkinson's Disease (PD) is a progressively neurodegenerative disorder, implicitly characterized by a stepwise loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) and explicitly marked by bradykinesia, rigidity, resting tremor and postural instability. Currently, therapeutic approaches available are mainly palliative strategies, including L-3,4-dihydroxy-phenylalanine (L-DOPA) replacement therapy, DA receptor agonist and deep brain stimulation (DBS) procedures. As the disease proceeds, however, the pharmacotherapeutic efficacy is inevitably worn off, worse still, implicated by side effects of motor response oscillations as well as L-DOPA induced dyskinesia (LID). Therefore, the frustrating status above has propeled the shift to cell replacement therapy (CRT), a promising restorative therapy intending to secure a long-lasting relief of patients' symptoms. By far, stem cell lines of multifarious origins have been established, which can be further categorized into embryonic stem cells (ESCs), neural stem cells (NSCs), induced neural stem cells (iNSCs), mesenchymal stem cells (MSCs), and induced pluripotent stem cells (iPSCs). In this review, we intend to present a compendium of preparation and application of multifarious stem cells, especially in relation to PD research and therapy. In addition, the current status, potential challenges and future prospects for practical CRT in PD patients will be elaborated as well.
Published Version: doi:10.3389/fnagi.2016.00117
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885841/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:27662110
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters